Strong Top-Line Growth
Q1 2026 sales of $547 million, up 11% year-over-year and up 5% sequentially; underlying growth excluding favorable FX and extra days estimated at 5%–6%.
Broad-Based Segment Performance
Consumer & Specialties sales $297 million, +11% YoY; Engineered Solutions sales $250 million, +12% YoY; all four product lines grew versus prior year.
Robust Product-Line Gains
Household & Personal Care sales $142 million, +16% YoY; Cat litter grew 19% YoY (record quarter); Specialty Additives $154 million, +6% YoY; Environmental & Infrastructure $67 million, +24% YoY (infrastructure drilling +46% YoY).
Profitability and EPS Upside
Operating income (excluding special items) $68 million, +7% YoY; diluted EPS $1.38, +21% YoY (excluding special items); segment operating income improvements (Engineered Solutions operating income $39 million, +14% YoY, 15.7% margin).
Cash Flow and Balance Sheet Strength
Q1 cash from operations $32 million, up $37 million YoY; capital expenditures $23 million in Q1 (FY guidance $90–$100 million); net leverage at 1.7x EBITDA; free cash flow target 6%–7% of sales for the year.
Growth Investments Delivering
On track to deliver $100 million of incremental annualized revenue in 2026; North America cat litter expansions fully online and ramping, China cat litter facility ramping (fully functional by H2), oil purification expansion (supporting SAF) commissioning late Q2 with related product sales +14% YoY.
Pipeline and New Technology Momentum
FLUORO-SORB: 10 full-scale municipal installations operating/contracted with ~10 additional implementations expected in H2 2026 and more in process; MINSCAN installations on track with share gains in North American steel; multiple paper & packaging satellite ramps on schedule.
Cautious but Upside-Grounded Guidance
Q2 2026 sales guidance ~ $560 million (≈ +6% YoY); Q2 operating income ~ $80 million; Q2 EPS $1.60–$1.65; full-year projected mid-single-digit sales growth and ~14% operating margin, with potential upside if markets remain constructive.